Riggs Asset Managment Co. Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Riggs Asset Managment Co. Inc.
- $321 Million
- Q1 2025
A detailed history of Riggs Asset Managment Co. Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Riggs Asset Managment Co. Inc. holds 46 shares of REGN stock, worth $25,902. This represents 0.01% of its overall portfolio holdings.
Number of Shares
46
Previous 45
2.22%
Holding current value
$25,902
Previous $32,000
9.38%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding REGN
# of Institutions
1,449Shares Held
84.9MCall Options Held
1.39MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.3 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.76 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.19 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.7 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.25 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $60.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...